Petros Pharmaceuticals, Inc. (PTPI) Operating margin 2020–2024
Petros Pharmaceuticals, Inc. (PTPI) operating margin by fiscal year — reported operating income divided by reported revenue.
-90.5%FY2024 · since FY2020: -180.8% → -90.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -90.5% | +143.4 pp |
| FY2023 | -233.9% | +98.5 pp |
| FY2022 | -332.4% | -101.3 pp |
| FY2021 | -231.1% | -50.3 pp |
| FY2020 | -180.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice